{
    "ticker": "ASRV",
    "name": "Assertio Holdings, Inc.",
    "description": "Assertio Holdings, Inc. is a pharmaceutical company focused on developing and commercializing innovative therapeutics for patients suffering from pain and related conditions. The company was established with a mission to provide effective and accessible treatments while ensuring the highest standards of safety and efficacy. Assertio's portfolio includes a wide range of prescription medications that target various pain management needs, including chronic pain, postoperative pain, and other indications. The company is particularly known for its commitment to addressing the opioid crisis by introducing non-opioid alternatives that help manage pain without the risks associated with traditional opioid therapy. Assertio leverages advanced drug delivery technologies and a robust clinical development pipeline to bring new products to market, ensuring that patients have access to cutting-edge treatments. The company operates with a strong emphasis on corporate responsibility, focusing on ethical practices and community engagement to improve patient outcomes and support healthcare providers. With an experienced management team and a dedicated workforce, Assertio continues to innovate in the pharmaceutical industry, striving to enhance the quality of life for patients worldwide.",
    "industry": [
        "Pharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "Lake Forest, Illinois, USA",
    "founded": "2016",
    "website": "https://www.assertiotx.com",
    "ceo": "Danile O. W. Houghton",
    "social_media": {
        "twitter": "https://twitter.com/AssertioTX",
        "linkedin": "https://www.linkedin.com/company/assertio-holdings/"
    },
    "investor_relations": "https://ir.assertiotx.com",
    "key_executives": [
        {
            "name": "Danile O. W. Houghton",
            "position": "CEO"
        },
        {
            "name": "Gordon R. McCulloh",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Pain Management",
            "products": [
                "Zycosan",
                "Nucynta"
            ]
        }
    ],
    "seo": {
        "meta_title": "Assertio Holdings, Inc. | Innovative Pain Management Solutions",
        "meta_description": "Explore Assertio Holdings, Inc., a leader in pharmaceutical solutions for pain management. Discover our commitment to innovation and patient health.",
        "keywords": [
            "Assertio",
            "Pain Management",
            "Pharmaceuticals",
            "Non-Opioid Treatments",
            "Healthcare"
        ]
    },
    "faq": [
        {
            "question": "What is Assertio known for?",
            "answer": "Assertio is known for developing innovative therapeutics for pain management, focusing on non-opioid alternatives."
        },
        {
            "question": "Who is the CEO of Assertio?",
            "answer": "Danile O. W. Houghton is the CEO of Assertio Holdings, Inc."
        },
        {
            "question": "Where is Assertio headquartered?",
            "answer": "Assertio is headquartered in Lake Forest, Illinois, USA."
        },
        {
            "question": "What are Assertio's main products?",
            "answer": "Assertio's main products include Zycosan and Nucynta."
        },
        {
            "question": "When was Assertio founded?",
            "answer": "Assertio was founded in 2016."
        }
    ],
    "competitors": [
        "PFE",
        "JNJ",
        "ABBV"
    ],
    "related_stocks": [
        "MRK",
        "GILD",
        "BMY",
        "AMGN"
    ]
}